First-in-human phase I study of DT-9081, a selective EP4 receptor antagonist, in advanced solid tumors
Year: 2026
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
Authors: Rachel Galot, Zahra Castel-Ajgal, Nuria Kotecki, Christiane Jungels, Jean-Pierre Delord, Iphigenie Korakis, Samira El-Farouk, Claire Jouffroy-Zeller, Anne Quesnel, Carolina Duarte, Abdelkrim Taamma, Thomas Maurin, Lola Lecru, Antoine Mousson, Orphée Blanchard, Anne-Laure Blayo, Nathalie Lenne, Stephan Schann, Xavier Leroy, Jean-Marie Cuillerot, Christophe Le Tourneau, Jean-Pascal Machiels
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7212947206